T Sathyapalan
Overview
Explore the profile of T Sathyapalan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sathyapalan T, Shepherd J, Atkin S, Kilpatrick E
Diabetes Obes Metab
. 2013 Jan;
15(8):767-9.
PMID: 23356580
The pleiotropic effect of statins may be mediated in part through raising 25 hydroxy vitamin D (25OHD) concentrations. It has also been shown that an increase in oxidative stress and...
12.
Sathyapalan T, Atkin S
Eur J Endocrinol
. 2011 Nov;
166(4):575-83.
PMID: 22096112
Polycystic ovary syndrome (PCOS) has been associated with increased cardiovascular risk (CVR) markers, but population studies have not clarified whether there is an increase in cardiovascular morbidity and mortality. Four...
13.
Dickerson E, Sathyapalan T, Knight R, Maguiness S, Killick S, Robinson J, et al.
J Assist Reprod Genet
. 2011 Nov;
28(12):1223-8.
PMID: 22071884
Purpose: There is increasing concern that environmental chemicals have a direct effect on fertility. Heavy metals such as mercury have been shown to affect various organ systems in humans including...
14.
15.
Thong K, Jose B, Blann A, Cull M, Mills A, Sathyapalan T, et al.
Diabetes Res Clin Pract
. 2011 Jun;
93(2):e87-e91.
PMID: 21636161
It is uncertain what should be done with insulin dose if starting exenatide. In the ABCD nationwide exenatide audit, many patients with type 2 diabetes had worsened glycaemia when insulin...
16.
Sathyapalan T, Atkin S
Minerva Endocrinol
. 2011 Apr;
36(2):147-56.
PMID: 21519323
There is a growing body of evidence to suggest that type 2 diabetes is associated with a generalised activation of the innate immune system, in which there is a chronic...
17.
Thong K, Jose B, Sukumar N, Cull M, Mills A, Sathyapalan T, et al.
Diabetes Obes Metab
. 2011 Mar;
13(8):703-10.
PMID: 21410858
Aim: To assess the extent, safety, efficacy and tolerability of reported off-licence exenatide use through a nationwide audit. Methods: The Association of British Clinical Diabetologists hosted a password-protected, online collection...
18.
Dawson A, Mellor D, Sathyapalan T, Kilpatrick E, Atkin S
Diabet Med
. 2010 Dec;
28(1):124-5.
PMID: 21166856
No abstract available.
19.
Mellor D, Sathyapalan T, Kilpatrick E, Beckett S, Atkin S
Diabet Med
. 2010 Oct;
27(11):1318-21.
PMID: 20968113
Aim: To examine the effects of chocolate on lipid profiles, weight and glycaemic control in individuals with Type 2 diabetes. Methods: Twelve individuals with Type 2 diabetes on stable medication...
20.
Sathyapalan T, Atkin S, Kilpatrick E
Diabetes Obes Metab
. 2010 Jun;
12(6):540-4.
PMID: 20518809
Aim: The benefit of direct, as opposed to calculated, low density lipoprotein -cholesterol (LDL-C) measurement remains unclear. This study compared the biological variability of direct LDL in patients with type...